Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: N Engl J Med. 2015 Feb 26;372(9):825–834. doi: 10.1056/NEJMoa1408913

Table 4. Distribution of C. difficile Strains, According to Epidemiologic Category.

*

Strain Community-Associated CDI (N = 735) Health Care–Associated CDI (N = 629)
no. of cases (%)
NAP1 138 (18.8) 193 (30.7)
NAP1-related 13 (1.8) 20 (3.2)
NAP2 13 (1.8) 10 (1.6)
NAP3 3 (0.4) 12 (1.9)
NAP4 84 (11.4) 65 (10.3)
NAP5 3 (0.4) 6 (1.0)
NAP6 56 (7.6) 27 (4.3)
NAP7 25 (3.4) 13 (2.1)
NAP7-related 2 (0.3) 2 (0.3)
NAP8 5 (0.7) 1 (0.2)
NAP9 22 (3.0) 9 (1.4)
NAP10 21 (2.9) 15 (2.4)
NAP11 79 (10.7) 63 (10.0)
NAP12 9 (1.2) 16 (2.5)
Unnamed§ 245 (33.3) 163 (25.9)
Could not be typed 17 (2.3) 14 (2.2)
*

Molecular typing was performed with the use of pulsed-field gel electrophoresis (PFGE). PFGE types represented the following ribotypes on polymerase-chain-reaction assay, according to an analysis that was performed on a random sample of 35 of the most prevalent NAP (North American PFGE) types: NAP1, 027; NAP4, 020; NAP6, 002; NAP7, 078; and NAP11, 106.

This strain has characteristics of NAP1 (i.e., positive for toxins A and B and C. difficile binary toxin with a 18-bp deletion in tcdC) but does not meet the 80% cutoff for relatedness on PFGE.

This strain has characteristics of NAP7 (i.e., positive for toxins A and B and C. difficile binary toxin with a 39-bp deletion in tcdC) but does not meet the 80% cutoff for relatedness.

§

The strains in the unnamed category include 80 PFGE types that do not fall within NAP1 through NAP12.

DNA from these samples produced no bands on PFGE after three attempts.